Atlas FDA

SIR-SPHERES

FDA premarket approval P990065 · decided 2002-03-05

Approval details

PMA number
P990065
Trade name
SIR-SPHERES
Generic name
Microspheres radionuclide
Applicant
Sirtex Medical, Inc.
Date received
1999-10-25
Decision date
2002-03-05
Days to decision
862 days
Decision code
APPR
Product code
NAW
Advisory committee
Radiology
Expedited review
No
Location
Woburn, MA
Statement
APPROVAL FOR SIR-SPHERES. THE DEVICE IS INDICATED FOR THE TREATMENT OF UNRESECTABLE METASTATIC LIVER TUMORS FROM PRIMARY COLORECTAL CANCER WITH ADJUVANT INTRA-HEPATIC ARTERY CHEMOTHERAPY (IHAC) OF FUDR (FLOXURIDINE).

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.